Biohaven Ltd.
BHVN
$38.97
$0.431.12%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -408.17M | -464.52M | -430.80M | -543.74M | -570.28M |
| Total Depreciation and Amortization | 6.91M | 5.36M | 4.20M | 2.79M | 1.39M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 44.92M | 134.58M | 148.13M | 260.18M | 299.81M |
| Change in Net Operating Assets | 24.61M | 32.33M | -14.53M | -35.72M | -28.60M |
| Cash from Operations | -331.73M | -292.25M | -293.00M | -316.49M | -297.69M |
| Capital Expenditure | -3.05M | -2.88M | -6.15M | -6.56M | -6.07M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 0.00 | 0.00 | -35.00M | -35.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 132.88M | -127.39M | -187.19M | -264.04M | -263.72M |
| Cash from Investing | 129.83M | -130.27M | -193.35M | -305.60M | -304.79M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 247.92M | 284.26M | 284.26M | 284.26M | 284.26M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -36.01M | 212.60M | 379.80M | 486.98M | 483.34M |
| Cash from Financing | 211.91M | 496.85M | 664.05M | 771.23M | 767.60M |
| Foreign Exchange rate Adjustments | -497.00K | 242.00K | 282.00K | 444.00K | 429.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.52M | 74.57M | 177.99M | 149.58M | 165.55M |
